The role of the cerebellum in movement and thought
Our research focuses on how people produce coordinated movement and coordinated thought, and how these abilities may be impacted by cerebellar degeneration.
Link to Enroll: https://tinyurl.com/53ycmrcu
About the Study
Eligible Ataxia Types
Spinocerebellar Ataxia (any subtype) and/or Cerebellar Degeneration of Unknown Origin
Type of Study
Research Study
Clinical Trial Phase
N/A
Age Range
Adult 18+
Study Start Date
01/01/2023
Estimated Completion Date
12/31/2026
IRB Approval #
University of California IRB:
2016-02-8439
Location(s)
Remote
Online video conference (Zoom, Skype, etc)
Contact Information
Richard Ivry
ivry@berkeley.edu
Email 2 – ivrycognac@berkeley.edu
Phone – 510-326-6658
What does participation in the study entail?
The study will be conducted online, meaning that it is from your home computer. The experiment will take between 40 minutes to 60 minutes. Participants can complete the experiment whenever it is most convenient for them.
What are the potential benefits for participants?
Participants will be financially compensated for their time at a $20/hour rate.
What are the potential risks for participants?
There are no risks for participants.
Is there financial compensation?
Yes. $20 per hour, for 1-2 hours.
Is there travel reimbursement?
No. Not applicable.
Who is eligible?
Adults with a clinical diagnosis of cerebellar ataxia and/or cerebellar degeneration (due to SCA or unknown origin) are eligible. In addition, we are also actively recruiting age-matched control participants without cerebellar impairment.
Additional Information or Resources
Download Patient Information Flier.
View Other Research Opportunities
Using MRI neurofeedback to enhance motor function in ataxia
The purpose of this study is to use a form of brain imaging (real-time functional magnetic resonance imaging, rt-fMRI) combined with neurofeedback, to train people with cerebellar ataxia to improve Read More…
Remote Assessment of Cognition, Affect, and Motor Function in Ataxias
This study aims to better understand how different brain and body functions (movement, speech, thinking skills, and mood) are affected in spinocerebellar ataxias, and how these functions change over the Read More…
Understanding the Spectrum of SCA1, SCA2, SCA3, SCA6 Through the Eyes of Patients and Caregivers
Biohaven Pharmaceuticals is now enrolling patients and spouses/parent/caregiver in a research study of patients and families affected by SCA. The study is regarding the burden of SCA types 1, 2, Read More…
